Literature DB >> 673546

Effect of various phototherapy regimens on bilirubin decrement.

F F Rubaltelli, V Zanardo, B Granati.   

Abstract

Continuous phototherapy in full-term newborns was found to be more effective than intermittent illumination. Treatment efficacy was also related to age and the initial bilirubin level of the infants. In fact, the reported data indicate an increased therapeutic effect in newborns affected with nonhemolytic hyperbilirubinemia who had an initial bilirubin level greater than 15 mg/dl as compared to neonates with an initial bilirubin level less than 15 mg/dl. The light treatment was also more effective in infants older than 3 days, possibly because of an increased ligandin and conjugating capacity. Shielding the hepatic area during illumination significantly decreases the efficiency of this treatment, suggesting that the liver could also be a phototherapeutic action site.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 673546

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Use of phototherapy for neonatal hyperbilirubinemia. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1986-06-01       Impact factor: 8.262

2.  Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice.

Authors:  S P Lau; K P Fung
Journal:  Arch Dis Child       Date:  1984-09       Impact factor: 3.791

3.  The effects of shielding the hepatic area on the clinical response to phototherapy.

Authors:  T Hegyi; V Brantley; I M Hiatt
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

4.  Phototherapy in neonatal hyperbilirubinemia.

Authors:  P K Misra; R Kaul
Journal:  Indian J Pediatr       Date:  1980 Mar-Apr       Impact factor: 1.967

Review 5.  Management of neonatal hyperbilirubinaemia and prevention of kernicterus.

Authors:  F F Rubaltelli; P F Griffith
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

6.  Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial.

Authors:  Monica Sachdeva; Srinivas Murki; Tejo Pratap Oleti; Hemasree Kandraju
Journal:  Eur J Pediatr       Date:  2014-07-09       Impact factor: 3.183

Review 7.  Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy.

Authors:  Kavita Bhola; Jann P Foster; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2015-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.